scispace - formally typeset
M

Maxime Hentzien

Researcher at University of Reims Champagne-Ardenne

Publications -  62
Citations -  502

Maxime Hentzien is an academic researcher from University of Reims Champagne-Ardenne. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 9, co-authored 35 publications receiving 248 citations. Previous affiliations of Maxime Hentzien include Reims University.

Papers
More filters
Journal ArticleDOI

Should RT-PCR be considered a gold standard in the diagnosis of COVID-19?

TL;DR: Since the beginning of this disease epidemic caused by the severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2), reverse transcriptase polymerase chain reaction (RT‐PCR) has routinely been used to confirm diagnosis, however, several authors have pointed out the poor performance of this technique, particularly in terms of sensitivity.
Journal ArticleDOI

A monoclonal antibody stands out against omicron subvariants: a call to action for a wider access to bebtelovimab

TL;DR: Bebelovimab (175 mg dosage) is licensed by Eli Lilly, which is a neutralising immunoglobulin (Ig)-G1 monoclonal antibody targeting the spike protein of SARS-CoV-2 as mentioned in this paper .
Journal ArticleDOI

Epidemiology of autoimmune and inflammatory diseases in a French nationwide HIV cohort

TL;DR: It is shown that some IAD are not rare among PLHIV and occur mostly in patients with immuno-virological control under cART, and the higher frequency of HCV or hepatitis B virus coinfection for some Iad is confirmed.
Journal ArticleDOI

Factors associated with deaths from suicide in a French nationwide HIV-infected cohort.

TL;DR: In this paper, the authors studied demographic, socio-economic, psychiatric history and immunovirological characteristics associated with death from suicide in the French multicenter Dat'AIDS cohort, from January 2000 to July 2013.